K13.3 Hairy leukoplakia

Name of the Condition

• Hairy Leukoplakia

Summary

Hairy leukoplakia is a benign, hyperkeratotic lesion of the oral mucosa, typically appearing as white, corrugated patches that cannot be scraped off. It is most commonly associated with immunosuppression, particularly in individuals with HIV/AIDS, and may also occur in other immunocompromised states. The condition is characterized by its distinct clinical appearance and is often asymptomatic but may cause cosmetic concerns or mild discomfort.

Causes

Hairy leukoplakia is caused by the reactivation of the Epstein-Barr virus (EBV) in the oral epithelium, typically in the setting of immunosuppression. The virus induces hyperkeratosis and epithelial changes, leading to the characteristic white, raised lesions. While EBV is the primary etiologic agent, the condition arises only when the immune system is unable to control viral replication.

Risk Factors

• Immunocompromised states (e.g., HIV/AIDS, organ transplantation, chemotherapy)
• Advanced age
• Chronic immunosuppressive therapy
• Malnutrition or vitamin deficiencies
• Substance use (e.g., tobacco, alcohol)

Symptoms

• White, raised, corrugated patches on the lateral tongue or other oral mucosal surfaces
• Lesions that are not painful or easily removable
• Asymptomatic in many cases, though some may report mild irritation or cosmetic concerns
• May be bilateral or unilateral, with a predilection for the lateral tongue

Diagnosis

Diagnosis is primarily clinical, based on the characteristic appearance of the lesions and their location. A biopsy may be performed to confirm the diagnosis, showing hyperkeratosis, epithelial hyperplasia, and EBV-infected cells. Additional testing, such as HIV screening, may be considered in appropriate clinical contexts to identify underlying immunosuppression.

Treatment Options

Treatment is often not required for asymptomatic cases. For symptomatic or cosmetically concerning lesions, options may include:

• Topical antiviral agents (e.g., acyclovir)
• Systemic antiretroviral therapy in HIV-positive patients
• Laser therapy or cryotherapy for lesion removal
• Monitoring for changes in lesion appearance or associated symptoms

Prognosis and Follow-Up

The prognosis is generally favorable, with lesions often persisting or fluctuating in size but rarely progressing to malignancy. In immunocompromised individuals, resolution may occur with improved immune function (e.g., antiretroviral therapy). Regular follow-up is recommended to monitor for changes in lesion characteristics or signs of underlying disease progression.

Complications

• Persistent or recurrent lesions despite treatment
• Cosmetic concerns affecting quality of life
• Rare association with oral candidiasis or other opportunistic infections in immunocompromised patients
• Potential for misdiagnosis if lesions are atypical or in non-immunocompromised individuals

Lifestyle & Prevention

• Maintain good oral hygiene to reduce secondary infections
• Avoid tobacco and excessive alcohol use, which may exacerbate oral mucosal changes
• Ensure adequate nutrition and immune support, particularly in immunocompromised individuals
• Regular dental check-ups to monitor oral health and detect changes early

When to Seek Professional Help

• If lesions change in appearance, size, or texture
• If pain, bleeding, or other symptoms develop
• If there is uncertainty about the diagnosis or concern for underlying immunosuppression
• For individuals with known HIV/AIDS or other immunocompromising conditions, especially if new oral lesions appear

Tips for Medical Coders

When coding for hairy leukoplakia (ICD10CM code K13.3), ensure documentation supports the clinical diagnosis, including lesion characteristics (e.g., white, corrugated, non-removable) and location (e.g., lateral tongue). Note any associated risk factors (e.g., HIV status) or treatment provided, as these may impact coding specificity. Avoid coding for asymptomatic lesions unless clinically relevant or documented.